Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions (Q44136566)

30 November 2017

Lack of effects of prolonged treatment with phenobarbital or phenytoin on the expression of P-glycoprotein in various rat brain regions (English)

1 reference

30 November 2017

1 reference

2

1 reference

30 November 2017

Ulrike Seegers

1

1 reference

PubMed ID

12231384

30 November 2017

Wolfgang Löscher

series ordinal

3

1 reference

PubMed ID

12231384

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

European Journal of Pharmacology

30 November 2017

1 reference

30 November 2017

451

1 reference

30 November 2017

2

1 reference

30 November 2017

149-155

1 reference

Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Regulation of biliary drug efflux pump expression by hormones and xenobiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

High levels of P-glycoprotein detected in isolated brain capillaries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Multidrug resistance: molecular mechanisms and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Comparison of the anticonvulsant efficacy of primidone and phenobarbital during chronic treatment of amygdala-kindled rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Blood-brain barrier biology and methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Clinical aspects and biological bases of drug-resistant epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Clinically significant pharmacokinetic drug interactions with benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

MDR1 gene expression in brain of patients with medically intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Implications and consequences of enzyme induction on preclinical and clinical drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

Multidrug-resistance transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902235-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(02)02235-5

1 reference

30 November 2017

1 reference

PubMed ID

12231384